Monopar Therapeutics Inc.
1000
Skokie Blvd., Suite 350
Wilmette,
Illinois 60091
October
2, 2019
VIA EDGAR
US
Securities and Exchange Commission
Division
of Corporation Finance
100 F
Street, NE
Washington,
DC 20549
Re:
Monopar
Therapeutics Inc.
Registration Statement on Form S-1
File No. 333-233303
Ladies
and Gentlemen:
In
prior correspondence, dated September 30, 2019, Monopar
Therapeutics Inc. (the “Company”) requested that the
above-referenced Registration Statement be declared effective at 4
p.m., Eastern time, on October 2, 2019 (the “Acceleration
Request”). The Acceleration Request is hereby withdrawn by
the Company.
Please
contact John Harrington of Baker & Hostetler LLP at (216)
861-6697 with any questions regarding the foregoing.
Very
truly yours,
|
|
Monopar
Therapeutics Inc.
|
|
|
|
|
|
|
|
By:
|
/s/
Chandler D.
Robinson
|
|
|
|
|
Name: Chandler D.
Robinson
|
|
|
|
|
Title:
Chief
Executive Officer
|
|